WHAT YOU NEED TO KNOW: Despite Big Pharma spending hundreds of millions of dollars on lobbyists, marketing and “legal-fortress building” as Fortune reported in a must-read piece last month, there is a growing chorus of bipartisan support in Congress for reforming the U.S. patent system.  More and more lawmakers are acknowledging that Big Pharma’s rampant […]

Continue Reading

Bipartisan Effort Grows to Stop Big Pharma From Gaming System & Price-Gouging Patients WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and others, today announced that the Niskanen Center has joined its organization:  “The Niskanen Center is a welcome addition to […]

Continue Reading

Thanks Committee members for highlighting the damaging impact of Big Pharma’s abuse of the U.S. patent system to maintain drug monopolies and prevent or delay generic alternative medications and life-saving treatments for patients WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates […]

Continue Reading

IN CASE YOU MISSED IT: This week, the chorus of evidence and support for patent reform has grown even larger with three important news items that demonstrate both the extent of Big Pharma’s patent abuse and the much-needed relief that substantive patent reform will bring American patients. Axios published the below article yesterday keying off […]

Continue Reading

WHAT YOU NEED TO KNOW: USA Today Editorial Board: How Big Pharma Plays Games With Drug Patents And How To Combat It President Donald Trump came into office promising to do something about the inflated prices Americans pay for prescription drugs. He considered limiting rebates to the middlemen between insurance plans and drug companies but […]

Continue Reading

Coalition urges Congress to reject harmful bill removing oversight review process currently used to protect against Big Pharma’s rampant patent abuse leading to significant higher prescription drug prices for patients WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and others released the […]

Continue Reading

IN CASE YOU MISSED IT: The New York Times published the op-ed below on Saturday acknowledging the role patent abuse plays in the drug pricing crisis that faces American consumers. This op-ed reinforces what CAPA has been telling lawmakers, that Big Pharma’s abuse of the patent system is hurting patients across the nation. “There is a […]

Continue Reading

WHAT YOU NEED TO KNOW: In an important step toward reining in Big Pharma, the Senate Judiciary Committee approved yesterday the bipartisan Affordable Prescriptions for Patients Act, sponsored by U.S. Senators John Cornyn (R-TX) and Richard Blumenthal (D-CT), despite pushback from Big Pharma. Matthew Lane, executive director of the Coalition Against Patent Abuse: “We thank […]

Continue Reading

Applauds Senators Cornyn and Blumenthal for their efforts to stop the major drug companies from abusing the U.S. patent system to delay or prevent patients from accessing more affordable generic alternative medications and treatments. WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates […]

Continue Reading

Study Finds Average Annual Cost For Specialty Drugs Climbed To Almost $79,000 In 2017 WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and others released the following statement today in response to a new AARP report which found that the average […]

Continue Reading